Amedisys (AMED) Tops Q2 EPS by 24c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Income tax expense: -6.69M
Today's EPS Names:
UBAB, LOAN, FITB, More
Financial Fact:
Income tax expense: -6.69M
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.47, $0.24 better than the analyst estimate of $1.23. Revenue for the quarter came in at $557.9 million versus the consensus estimate of $583.12 million.
GUIDANCE:
Amedisys sees FY2022 revenue of $2.29-2.31 billion, versus the consensus of $2.35 billion.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan upgrades 3M, Emerson Electric to Overweight ahead of earnings
- Simmons First National Corp (SFNC) Misses Q2 EPS by 2c
- Travelers (TRV) Tops Q2 EPS by $4.92
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
